ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Paladin Labs Inc. Announces Approval of Envarsus PA (tacrolimus prolonged-release tablets) in Canada firstwordpharma
February 23, 2019Paladin Labs Inc. and Endo Ventures Limited, subsidiaries of Endo International plc (NASDAQ:??ENDP), today announced Health Canada's approval of Envarsus PA?(tacrolimus prolonged-release tablets) for the prophylaxis of organ rejection in kidney or liver t
Pharma Sources Insight January 2025
